| Literature DB >> 30723266 |
Swapnil Kumar1, Kumari Snehkant Lata1, Priyanka Sharma1, Shivarudrappa B Bhairappanavar1, Subhash Soni1, Jayashankar Das2.
Abstract
Leptospirosis is the most emerging zoonotic disease of epidemic potential caused by pathogenic species of Leptospira. The bacterium invades the host system and causes the disease by interacting with the host proteins. Analyzing these pathogen-host protein interactions (PHPIs) may provide deeper insight into the disease pathogenesis. For this analysis, inter-species as well as intra-species protein interactions networks of Leptospira interrogans and human were constructed and investigated. The topological analyses of these networks showed lesser connectivity in inter-species network than intra-species, indicating the perturbed nature of the inter-species network. Hence, it can be one of the reasons behind the disease development. A total of 35 out of 586 PHPIs were identified as key interactions based on their sub-cellular localization. Two outer membrane proteins (GpsA and MetXA) and two periplasmic proteins (Flab and GlyA) participating in PHPIs were found conserved in all pathogenic, intermediate and saprophytic spp. of Leptospira. Furthermore, the bacterial membrane proteins involved in PHPIs were found playing major roles in disruption of the immune systems and metabolic processes within host and thereby causing infectious disease. Thus, the present results signify that the membrane proteins participating in such interactions hold potential to serve as effective immunotherapeutic candidates for vaccine development.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30723266 PMCID: PMC6363727 DOI: 10.1038/s41598-018-38329-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Network parameters for all inter-species and intra-species networks.
| Network | N | NC | <k> | <CC> | NCC | <BC> |
|---|---|---|---|---|---|---|
| PHPI | 655 | 1538 | 4.696183 | 0.1354224 | 4 | 964.2076 |
| LIC | 115 | 247 | 4.295652 | 0.4132618 | 10 | 150.2696 |
| HSA | 289 | 705 | 4.878893 | 0.3620147 | 28 | 379.8616 |
Total number of proteins (N) collected using database (described in the method section), Total number of connections (NC), Average degree (
Figure 1Degree distribution for the inter- and intra-species networks. Networks (A) HSA, (B) LIC and (C) PHPIs show that the degree distributions follow power law.
Figure 2Degree-Clustering coefficient correlations for the inter- and intra-species networks. Networks (A) HSA, (B) LIC and (C) PHPIs show that the degree-clustering coefficient correlations are negatively correlated.
Figure 3Degree-Betweenness correlations for the inter- and intra-species networks. Networks (A) HSA, (B) LIC and (C) PHPIs show that the degree-betweenness correlations are positively correlated.
Figure 4Eigen value distribution of inter- and intra-species networks. The plots depict similar distribution for all the three inter-species networks: (A) HSA; (B) LIC; and (C) PHPIs with a high degeneracy at zero.
Total 56 hub proteins of host H. sapiens.
| Rank | Protein | Degree |
|---|---|---|
| 1 | RAC1 | 31 |
| 2 | TP53 | 27 |
| 3 | NFKB1, POLR2A | 26 |
| 4 | FYN | 22 |
| 5 | CDC42 | 21 |
| 6 | ZAP70, SRSF3, HLA-DRA, JUN | 20 |
| 7 | DVL2 | 19 |
| 8 | PRPF8, CTNNB1 | 18 |
| 9 | B2M | 17 |
| 10 | SF3B1 | 16 |
| 11 | EEF1A1, HNRNPH2, ARRB1 | 15 |
| 12 | HDAC2, EEF2, SYNJ1, RAC2 | 14 |
| 13 | CDC16, STAT3, HNRNPA2B1, HLA-A, PTBP1, ELAVL1, ACTG1, SNAPC4 | 13 |
| 14 | HLA-B, HLA-E, PDIA3, JAK1, SH3GL1, ARPC3, CD4 | 12 |
| 15 | PSME2, PSMD3, DDX17, RANBP2, PSMB4, KHDRBS1 | 11 |
| 16 | DCTN3, EIF4A1, PLG, DMTF1, ITSN2, STAT6, YWHAZ, PSME1, NFKBIA, VWF, PAFAH1B1, TAF1, IRF9 | 10 |
Total 42 hub proteins of pathogen i.e. L. interrogans.
| Rank | Proteins | Degree |
|---|---|---|
| 1 | FusA | 42 |
| 2 | ClpB | 30 |
| 3 | PurC | 24 |
| 4 | GroL | 22 |
| 5 | GatA | 21 |
| 7 | RpoD | 19 |
| 8 | PyrG | 18 |
| 9 | CarB, GltX, GpmI | 17 |
| 10 | UvrB, GlyA, DnaJ, HisD | 16 |
| 11 | ArgS, Eno, MetK, Tuf | 15 |
| 12 | AsnS, UvrA, ArgG | 14 |
| 13 | CarA, DnaK, ProS | 13 |
| 14 | MetG, PurT, LeuS, DinB, ProA | 12 |
| 15 | IleS, LysS, LeuD, GcvP, PurD, GlmS | 11 |
| 16 | PyrB, ArgF, PrfB, PrfA, AlaS, SerS, GlyQS | 10 |
Figure 5Hub proteins of H. sapiens and L. interrogans in PHPIs. Red colored nodes are hub proteins from H. sapiens and yellow colored nodes are hub proteins from L. interrogans.
Sub-cellular localization distribution of L. interrogans proteins.
| Localization | Number of proteins, LIC |
|---|---|
| Outer membrane | 9 |
| Periplasmic | 4 |
| Inner membrane | 4 |
| Cytoplasmic | 128 |
Figure 6Sub-network of 13 membrane proteins and their first neighbors from the whole PHPIs network. Diamond shaped yellow colored nodes indicate 13 membrane proteins including 9 outer and 4 inner membrane proteins of L. interrogans, oval shaped yellow colored nodes indicate 25 other including cytoplasmic and periplasmic proteins of L. interrogans, and rectangular red colored nodes indicate 35 human proteins. Here, these oval and rectangular shaped nodes are the first neighbors of diamond shaped nodes.
Top 35 LIC-human protein-protein interactions.
| LIC Gene | LIC Protein Official full name | Human gene name | Human Protein Official full name | Biological process |
|---|---|---|---|---|
| alaS | Alanine–tRNA ligase | LPXN | Leupaxin | cell adhesion, negative regulation of B cell receptor signaling pathway |
| coaX | Type III pantothenate kinase | DEFA3 | Neutrophil defensin 3 | antimicrobial humoral response |
| feoB | Fe(2+) transporter FeoB | FADD | FAS-associated death domain protein | activation of cysteine-type endopeptidase activity |
| IGHG1 | Immunoglobulin heavy constant gamma 1 | B cell receptor signaling pathway | ||
| flgI | Flagellar P-ring protein | RBM39 | RNA-binding protein 39 | mRNA processing |
| PEAK1 | Pseudopodium-enriched atypical kinase 1 | cell migration | ||
| gatA | Glutamyl-tRNA(Gln) amidotransferase subunit A | CD74 | HLA class II histocompatibility antigen gamma chain | activation of MAPK activity, antigen processing and presentation of endogenous antigen |
| DOCK11 | Dedicator of cytokinesis protein 11 | B cell homeostasis | ||
| IFT122 | Intraflagellar transport protein 122 homolog | camera-type eye morphogenesis, iliary receptor clustering involved in smoothened signaling pathway | ||
| PHF20L1 | PHD finger protein 20-like protein 1 | regulation of transcription, DNA-templated | ||
| DVL2 | Segment polarity protein dishevelled homolog DVL-2 | beta-catenin destruction complex disassembly | ||
| TPP1 | Tripeptidyl-peptidase 1 | bone resorption, central nervous system development | ||
| DYSF | Dysferlin | muscle contraction, plasma membrane repair | ||
| COL4A2 | Collagen alpha-2(IV) chain | Angiogenesis | ||
| TMEM33 | Transmembrane protein 33 | cellular protein localization | ||
| NCF4 | Neutrophil cytosol factor 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | ||
| HLF | Hepatic leukemia factor | positive regulation of transcription from RNA polymerase II promoter | ||
| TNRC6A | Trinucleotide repeat-containing gene 6A protein | regulation of gene silencing by miRNA | ||
| NPDC1 | Neural proliferation differentiation and control protein 1 | regulation of immune response | ||
| IFT57 | Intraflagellar transport protein 57 homolog | activation of cysteine-type endopeptidase activity involved in apoptotic process | ||
| gcvT | Aminomethyltransferase | LPIN2 | Phosphatidate phosphatase LPIN2 | fatty acid catabolic process |
| ZMYM2 | Zinc finger MYM-type protein 2 | cytoskeleton organization | ||
| gpsA | Glycerol-3-phosphate dehydrogenase | HIVEP1 | Zinc finger protein 40 | multicellular organism development, signal transduction |
| htpX | Protease HtpX homolog | SEPT7 | Septin-7 | cell differentiation |
| metXA | Homoserine O-acetyltransferase | B2M | Beta-2-microglobulin | antibacterial humoral response |
| AKAP8L | A-kinase anchor protein 8-like | cell cycle G2/M phase transition, mitotic chromosome condensation | ||
| TACC1 | Transforming acidic coiled-coil-containing protein 1 | cell division | ||
| pgi | Glucose-6-phosphate isomerase | RBBP6 | E3 ubiquitin-protein ligase RBBP6 | cellular response to DNA damage stimulus, DNA replication |
| tgt | QueuinetRNA-ribosyltransferase | SMC4 | Structural maintenance of chromosomes protein 4 | cell division, kinetochore organization |
| SNAPC4 | snRNA-activating protein complex subunit 4 | cell differentiation | ||
| IMP3 | U3 small nucleolar ribonucleoprotein protein IMP3 | rRNA processing | ||
| uppP | Undecaprenyl-diphosphatase | PDCD6 | Programmed cell death protein 6 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| xseA | Exodeoxyribonuclease 7 large subunit | DKFZp434E0321 | Putative uncharacterized protein DKFZp434E0321 | cell adhesion |
| UTP6 | U3 small nucleolar RNA-associated protein 6 homolog | maturation of SSU-rRNA from tricistronicrRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA), rRNA processing | ||
| PTBP1 | Polypyrimidine tract-binding protein 1 | fibroblast growth factor receptor signaling pathway |
LIC proteins are referenced according to their UniProt/SwissProt protein coding gene and protein name (columns 1, and 2 respectively). Human proteins are referenced with their cognate gene name and their protein official full name with their main biological functions (columns 3, 4 and 5 respectively).
First 20 enriched GO process terms in human proteins targeted by bacteria.
| GO ID | GO Process term | Count | |
|---|---|---|---|
| GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 11 | 2.12E-09 |
GO:0002480 GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent | 7 13 | 2.17E-08 5.73E-08 |
| GO:0060333 | interferon-gamma-mediated signaling pathway | 12 | 1.80E-06 |
| GO:0098609 | cell-cell adhesion | 23 | 2.07E-06 |
| GO:0006397 | mRNA processing | 17 | 1.56E-05 |
| GO:0019882 | antigen processing and presentation | 9 | 7.47E-05 |
| GO:0006915 | apoptotic process | 31 | 1.55E-04 |
| GO:0060337 | type I interferon signaling pathway | 9 | 2.22E-04 |
| GO:0006457 | protein folding | 15 | 2.33E-04 |
| GO:0001916 | positive regulation of T cell mediated cytotoxicity | 5 | 2.55E-04 |
| GO:0016032 | viral process | 20 | 2.78E-04 |
| GO:0043066 | negative regulation of apoptotic process | 26 | 3.08E-04 |
| GO:0045087 | innate immune response | 25 | 3.26E-04 |
| GO:0071260 | cellular response to mechanical stimulus | 9 | 4.56E-04 |
| GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 35 | 4.78E-04 |
| GO:0030036 | actin cytoskeleton organization | 12 | 5.27E-04 |
| GO:0032355 | response to estradiol | 10 | 5.43E-04 |
| GO:0050690 | regulation of defense response to virus by virus | 6 | 6.57E-04 |
| GO:0034976 | response to endoplasmic reticulum stress | 9 | 6.62E-04 |
| GO:0017148 | negative regulation of translation | 8 | 6.79E-04 |
First 20 enriched GO function terms in human proteins targeted by bacteria.
| GO ID | GO function term | Count | |
|---|---|---|---|
| GO:0005515 | protein binding | 336 | 2.09E-24 |
| GO:0044822 | poly(A) RNA binding | 77 | 2.84E-14 |
| GO:0042802 | identical protein binding | 46 | 2.42E-07 |
| GO:0098641 | cadherin binding involved in cell-cell adhesion | 24 | 2.95E-06 |
| GO:0042605 | peptide antigen binding | 8 | 6.27E-06 |
| GO:0001948 | glycoprotein binding | 11 | 7.31E-06 |
| GO:0043621 | protein self-association | 8 | 1.88E-04 |
| GO:0019901 | protein kinase binding | 23 | 4.45E-04 |
| GO:0008134 | transcription factor binding | 19 | 5.78E-04 |
| GO:0050681 | androgen receptor binding | 7 | 5.89E-04 |
| GO:0003823 | antigen binding | 10 | 0.001620667 |
| GO:0044212 | transcription regulatory region DNA binding | 15 | 0.001630945 |
| GO:0031625 | ubiquitin protein ligase binding | 18 | 0.001695178 |
| GO:0005201 | extracellular matrix structural constituent | 8 | 0.001901561 |
| GO:0042803 | protein homodimerization activity | 34 | 0.001952651 |
| GO:0046977 | TAP binding | 3 | 0.002052872 |
| GO:0003756 | protein disulfide isomerase activity | 5 | 0.002409702 |
| GO:0003713 | transcription coactivator activity | 16 | 0.002546855 |
| GO:0051082 | unfolded protein binding | 10 | 0.002551929 |
| GO:0030881 | beta-2-microglobulin binding | 4 | 0.002580398 |
First 20 enriched KEGG pathway terms in human proteins targeted by bacteria.
| Pathway ID | Term | Gene count | |
|---|---|---|---|
| hsa04612 | Antigen processing and presentation | 15 | 8.31E-09 |
| hsa05416 | Viral myocarditis | 12 | 2.13E-07 |
| hsa05169 | Epstein-Barr virus infection | 19 | 2.37E-06 |
| hsa05168 | Herpes simplex infection | 18 | 6.02E-06 |
| hsa05203 | Viral carcinogenesis | 19 | 6.99E-06 |
| hsa05134 | Legionellosis | 9 | 7.62E-05 |
| hsa05140 | Leishmaniasis | 10 | 9.52E-05 |
| hsa05166 | HTLV-I infection | 19 | 1.37E-04 |
| hsa04145 | Phagosome | 14 | 1.93E-04 |
| hsa05332 | Graft-versus-host disease | 7 | 1.94E-04 |
| hsa05330 | Allograft rejection | 7 | 3.73E-04 |
| hsa04520 | Adherens junction | 9 | 5.31E-04 |
| hsa04940 | Type I diabetes mellitus | 7 | 7.54E-04 |
| hsa05161 | Hepatitis B | 12 | 0.001542118 |
| hsa05212 | Pancreatic cancer | 8 | 0.001550511 |
| hsa05320 | Autoimmune thyroid disease | 7 | 0.00235216 |
| hsa04622 | RIG-I-like receptor signaling pathway | 8 | 0.002389704 |
| hsa04621 | NOD-like receptor signaling pathway | 7 | 0.003137327 |
| hsa04514 | Cell adhesion molecules (CAMs) | 11 | 0.004296064 |
| hsa05210 | Colorectal cancer | 7 | 0.005713384 |